Abvc Biopharma (ABVC) Assets (2010 - 2026)
Abvc Biopharma's Assets came in at $19.4 million for Q2 2026, up 19.5% from $16.24 million a year earlier but down 1.7% from the prior quarter.
Powered by 
Analysis
Abvc Biopharma (ABVC) Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Abvc Biopharma's Assets was $21.06 million, up 179.3% from FY2024.
- Assets carries a five-year compound annual growth rate of 12.7% (FY2020 to FY2025).
- Going back by year, Assets was $7.54 million in FY2024 (-3.1%), $7.78 million in FY2023 (-18.7%), $9.58 million in FY2022 (-30.1%) and $13.7 million in FY2021 (+18.0%).
- The five-year range for quarterly Assets is $7.54 million (Q4 2024) to $21.21 million (Q3 2025).
- Year-over-year, Assets has increased for six consecutive quarters, with growth averaging 67.0% over the last eight quarters.
- The fastest year-over-year change in Assets over five years came in Q4 2025 (growth of 179.3%), and the weakest in Q3 2024 (a decline of 53.1%).
- Business Quant data shows ABVC's Assets at $19.73 million (Q1 2026), $21.06 million (Q4 2025) and $21.21 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Abvc Biopharma | 27.31 Mn | 29.30 Mn | - | 19.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 19.40 Mn |
| Mar 31, 2026 | 19.73 Mn |
| Dec 31, 2025 | 21.06 Mn |
| Sep 30, 2025 | 21.21 Mn |
| Jun 30, 2025 | 16.24 Mn |
| Mar 31, 2025 | 14.88 Mn |
| Dec 31, 2024 | 7.54 Mn |
| Sep 30, 2024 | 7.78 Mn |
| Jun 30, 2024 | 8.04 Mn |
| Mar 31, 2024 | 7.98 Mn |
| Dec 31, 2023 | 7.78 Mn |
| Sep 30, 2023 | 16.59 Mn |
| Jun 30, 2023 | 9.32 Mn |
| Mar 31, 2023 | 10.73 Mn |
| Dec 31, 2022 | 9.58 Mn |
| Sep 30, 2022 | 10.48 Mn |
| Jun 30, 2022 | 13.78 Mn |
| Mar 31, 2022 | 12.07 Mn |
| Dec 31, 2021 | 13.70 Mn |
| Sep 30, 2021 | 12.35 Mn |
API Access
Abvc Biopharma Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=ABVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "ABVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=ABVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();